Big Pharma Split (TSX:PRM) FCF Margin %: -32.12% (As of Dec. 2025)

What is Big Pharma Split FCF Margin %?

Big Pharma Split TSX:PRM 7 FCF Margin % is -32.12% as of Dec. 2025. GuruFocus rates TSX:PRM with a GF Score™ of 7/100 and a GF Value™ of C$1.80.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Big Pharma Split's Free Cash Flow for the six months ended in Dec. 2025 was C$-1.76 Mil. Big Pharma Split's Revenue for the six months ended in Dec. 2025 was C$5.48 Mil. Therefore, Big Pharma Split's FCF Margin % for the quarter that ended in Dec. 2025 was -32.12%.

As of today, Big Pharma Split's current FCF Yield % is -6.31%.

The historical rank and industry rank for Big Pharma Split's FCF Margin % or its related term are showing as below:

TSX:PRM' s FCF Margin % Range Over the Past 10 Years
Min: -7605.41 Med: 30.4 Max: 3862.54
Current: -16.04

During the past 9 years, the highest FCF Margin % of Big Pharma Split was 3862.54%. The lowest was -7605.41%. And the median was 30.40%.

TSX:PRM's FCF Margin % is not ranked
in the Asset Management industry.
Industry Median: 14.62 vs TSX:PRM: -16.04

Big Pharma Split FCF Margin % Related Terms

Big Pharma Split FCF Margin % Historical Data

* Premium members only.

The historical data trend for Big Pharma Split's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split FCF Margin % Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-167.94

30.40

3,862.54

392.43

-16.02

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
FCF Margin %	Get a 7-Day Free Trial												315.16	99.20	2.05	1,225.35	-32.12

TSX:PRM vs BLK, BX, KKR: FCF Margin % Comparison

For the Asset Management subindustry, Big Pharma Split's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split FCF Margin % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's FCF Margin % falls into.

Save Embed

7GF Score

Big Pharma Split Corp TSX:PRM

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Big Pharma Split FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Big Pharma Split's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-0.89	/	5.555
	=	-16.02 %

Big Pharma Split's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-1.761	/	5.483
	=	-32.12 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -32.12% mean?

Big Pharma Split (TSX:PRM) has a FCF Margin % of -32.12% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Big Pharma Split and its competitors.

Is Big Pharma Split's FCF Margin % too high?

Big Pharma Split's current FCF Margin % is -32.12%. Overall, Big Pharma Split has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.

How does Big Pharma Split's FCF Margin % compare to BLK and BX?

Big Pharma Split's FCF Margin % of -32.12% can be compared against companies in the Asset Management industry. The industry median FCF Margin % is 14.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for an Asset Management company?

The median FCF Margin % among Asset Management companies is 14.62, based on 1,461 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Big Pharma Split and its competitors. For the Asset Management industry, the median FCF Margin % is 14.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Big Pharma Split's current FCF Margin % is -32.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Big Pharma Split stock overvalued right now?

Big Pharma Split (TSX:PRM) has a current FCF Margin % of -32.12%. The stock's GF Value™ is C$1.80, compared to a current price of C$11.61 — trading 545% above its estimated fair value. The current FCF Margin % is -32.12%. Big Pharma Split's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Big Pharma Split (TSX:PRM), the current FCF Margin % is -32.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Big Pharma Split (TSX:PRM) Overvalued in 2026?

Based on GuruFocus' analysis, Big Pharma Split stock appears to be overvalued. The current stock price of C$11.61 is trading 545% above its estimated GF Value™ of C$1.80.

Key valuation signals for TSX:PRM:

FCF Margin %: -32.12%
GF Value™: C$1.80 vs. price of C$11.61 (545% above fair value)
GF Score™: 7/100

No single metric tells the full story. See the TSX:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Big Pharma Split Business Description

Industry Financial Services Asset Management

Comparable Companies XCNQ:LFG TSXV:ELC TSXV:LBI XCNQ:BRCH TSXV:MIVO XCNQ:MBAI XCNQ:PXI TSXV:CLCO XCNQ:FNQ XCNQ:GOAT BLK BX KKR TSX:BN OSTO:INVE A TSX:BAM APO AMP LSE:III OSTO:EQT

Other Exchanges PRM.PR.A.PFD:Canada

Address 610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website https://www.harvestportfolios.com

Big Pharma Split Corp is a closed end mutual fund corporation. The investment objective of the company is to provide shareholders with fixed cumulative preferential quarterly cash distributions and regular monthly cash distributions. The company has a presence in the United States, France, and the United Kingdom.

7GF Score

Get the complete analysis for TSX:PRM

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$11.61

Price

C$1.80

GF Value

View TSX:PRM Analysis

See FCF Margin % data for all stocks →